Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was "encouraged" by the company's dialogue with the FDA--but acknowledged recent setbacks. Moderna CEO Stéphane Bancel prepares to testify before the Senate on March 22, 2023 in Washington, DC. At the WIRED Health summit on Tuesday, Moderna CEO Stéphane Bancel said the recent changes to Covid-19 vaccine policy made by Health and Human Services secretary Robert F. Kennedy, Jr. are a "step backward." Moderna is one of the manufacturers of mRNA-based Covid-19 vaccines, and last month the company received approval from the Food and Drug Administration for an updated version of the shot . But as part of that approval, the FDA imposed new restrictions on who can receive the vaccine.

Motivation: Codon optimization of Open Reading Frame (ORF) sequences is essential for enhancing mRNA stability and expression in applications like mRNA vaccines, where codon choice can significantly impact protein yield which directly impacts immune strength. In this work, we investigate the use of a pre-trained protein language model (PPLM) for getting a rich representation of amino acids which could be utilized for codon optimization. This leaves us with a simpler fine-tuning task over PPLM in optimizing ORF sequences. Results: The ORFs generated by our proposed models outperformed their natural counterparts encoding the same proteins on computational metrics for stability and expression. They also demonstrated enhanced performance against the benchmark ORFs used in mRNA vaccines for the SARS-CoV-2 viral spike protein and the varicella-zoster virus (VZV). These results highlight the potential of adapting PPLM for designing ORFs tailored to encode target antigens in mRNA vaccines.

Human babies are far better at learning than even the very best large language models. To be able to write in passable English, ChatGPT had to be trained on massive data sets that contain millions upon millions of words. Children, on the other hand, have access to only a tiny fraction of that data, yet by age three they're communicating in quite sophisticated ways. A team of researchers at New York University wondered if AI could learn like a baby. What could an AI model do when given a far smaller data set--the sights and sounds experienced by a single child learning to talk?

Individual-based epidemiological models support the study of fine-grained preventive measures, such as tailored vaccine allocation policies, in silico. As individual-based models are computationally intensive, it is pivotal to identify optimal strategies within a reasonable computational budget. Moreover, due to the high societal impact associated with the implementation of preventive strategies, uncertainty regarding decisions should be communicated to policy makers, which is naturally embedded in a Bayesian approach. We present a novel technique for evaluating vaccine allocation strategies using a multi-armed bandit framework in combination with a Bayesian anytime $m$-top exploration algorithm. $m$-top exploration allows the algorithm to learn $m$ policies for which it expects the highest utility, enabling experts to inspect this small set of alternative strategies, along with their quantified uncertainty. The anytime component provides policy advisors with flexibility regarding the computation time and the desired confidence, which is important as it is difficult to make this trade-off beforehand. We consider the Belgian COVID-19 epidemic using the individual-based model STRIDE, where we learn a set of vaccination policies that minimize the number of infections and hospitalisations. Through experiments we show that our method can efficiently identify the $m$-top policies, which is validated in a scenario where the ground truth is available. Finally, we explore how vaccination policies can best be organised under different contact reduction schemes. Through these experiments, we show that the top policies follow a clear trend regarding the prioritised age groups and assigned vaccine type, which provides insights for future vaccination campaigns.

There has been an audible buzz about Jack Draper in tennis circles for a while. But in 2023 expect the 21-year-old from Sutton in south-west London, who also has a contract with IMG Models, to crash into the mainstream. He certainly has enough of the right stuff, including the whiplash serve and punishing groundstrokes on the court, and the looks and personality off it. Draper first advertised his talents by taking a set off Novak Djokovic at Wimbledon in 2021, but it was in 2022 that he really made his mark – shooting from No 265 in the world rankings at the start of the year to a career-high 42nd by the end. Along the way, he has taken several high-profile scalps, including the 2020 US Open winner Dominic Thiem and world No 4 Stefanos Tsitsipas. He still needs to improve his fitness and ability to see out big games, but when he does, anything is possible. His fellow Brit Cameron Norrie says he is "sure" Draper "can easily get into the top 10". Expect Draper to make bounding strides towards that goal in the coming months. It may feel as if footballer Beth Mead has already made her mark.

Few know that Coronavirus and its allied disease Covid-19 was first discovered by a data-mining program. HealthMap, a website run by Boston Children's Hospital, raised an alarm about multiple cases of pneumonia in Wuhan, China, rating its urgency at three on a scale of five. As it progressed, Governments struggled to deal with the unprecedented crisis on multiple fronts and were forced to look at innovative ways to augment their efforts; presenting an opportunity to leverage Artificial Intelligence (AI). AI was used in varied settings including drug discovery, testing, prevention and overcoming resource constraints, and its success opened a whole new door of possibilities. Here's a look at some of the most intuitive, innovative and advantageous uses of the technology during COVID-19, outlined under the four categories of diagnosis and prognosis, prediction and tracking, patient care and drug development: In Xinchang County, China, the drones delivered medical supplies to centers in need, and thermal sensing drones 14 identified people running fever, potentially infected with the virus.

With 2021 behind us, we're going down memory lane to highlight biotech innovations that shaped the year--with impact that will likely reverberate for many years to come. Covid-19 dominated the news, but science didn't stand still. CRISPR spun off variations with breathtaking speed, expanding into a hefty toolbox packed with powerhouse gene editors far more efficient, reliable, and safer than their predecessors. CRISPRoff, for example, hijacks epigenetic processes to reversibly turn genes on and off--all without actually snipping or damaging the gene itself. Prime editing, the nip-tuck of DNA editing that only snips--rather than fully cutting--DNA received an upgrade to precisely edit up to 10,000 DNA letters in a variety of cells.

The Covid-19 pandemic has drastically affected the world. Since last year, we have been witnessing the fatality of the pandemic, and it continues. Today, the pandemic is spreading like a wildfire with the mutated virus, across the globe. The nations have been stressing the significance of vaccines to fight this dreadful virus. Since 2020, many indigenous and foreign labs and medical research teams have been developing vaccines.